l General Information |
Product Name | Clindamycin Phosphate |
General description | Clindamycin Phosphate is a semi-synthetic, chlorinated broad spectrum antibiotic. |
Synonym | [(2R,3R,4S,5R,6R)-6-[(1S,2S)-2-chloro-1-[[(2S,4R)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] dihydrogen phosphate; Cleocin phosphate; NSC 618653 |
Purity | ≥96.0%(HPLC) | CAS Number | 24729-96-2 |
Formula | C18H34ClN2O8PS | Molecular Weight | 504.96 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or almost white solid |
Solubility(25℃) | DMSO | Very slightly soluble |
Ethanol | Very slightly soluble |
Water | ≥50mg/mL |
l Biological Information |
Biochem/Physiol Actions | Clindamycin Phosphate is the phosphate salt form of clindamycin, a semi-synthetic, chlorinated broad spectrum antibiotic produced by chemical modification of lincomycin. Clindamycin phosphate is used in topical preparations. |
Application | Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. |
l Packaging & Storage |
Packaging | 250mg; 1g |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
